The Lancet Gastroenterology & Hepatology in conversation with artwork

James Alexander immune responses to COVID-19 vaccination in patients with IBD

The Lancet Gastroenterology & Hepatology in conversation with

English - October 05, 2022 22:00 - 13 minutes - 9.51 MB
Life Sciences Science Education gut intestines ibs ibd bowel medicine research Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Filip Knop on liraglutide for bile acid diarrhoea

Next Episode: Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection

James Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease.

Read the full article:
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP)